WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005115441) COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/115441    International Application No.:    PCT/US2005/016530
Publication Date: 08.12.2005 International Filing Date: 10.05.2005
IPC:
A61K 38/29 (2006.01), A61K 47/00 (2006.01), A61K 47/30 (2006.01), A61K 47/48 (2006.01), A61P 5/18 (2006.01), A61P 19/10 (2006.01)
Applicants: NASTECH PHARMACEUTICAL COMPANY INC. [US/US]; 3450 Monte Villa Parkway, Bothell, WA 98021-8906 (US) (For All Designated States Except US).
QUAY, Steven, C. [US/US]; (US) (For US Only).
COSTANTINO, Henry, R. [US/US]; (US) (For US Only).
KLEPPE, Mary, S. [US/US]; (US) (For US Only).
LI, Ching-Yuan [US/--]; (US) (For US Only)
Inventors: QUAY, Steven, C.; (US).
COSTANTINO, Henry, R.; (US).
KLEPPE, Mary, S.; (US).
LI, Ching-Yuan; (US)
Agent: KNUDSEN, Peter, J.; Nastech Pharmaceutical Company Inc., 3450 Monte Villa Parkway, Bothell, WA 98021-8909 (US)
Priority Data:
60/570,113 10.05.2004 US
Title (EN) COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE
(FR) COMPOSITIONS ET METHODES AMELIOREES D'ADMINISTRATION PAR LES MUQUEUSES DE L'HORMONE PARATHYROIDE
Abstract: front page image
(EN)Pharmaceutical compositions and methods are described comprising at least a parathyroid hormone peptide (PTH) preferably PTH1-34 and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of PTH, for treating or preventing osteoporosis or osteopenia in a mammalian subject, preferably a human.
(FR)L'invention concerne des compositions pharmaceutiques et des méthodes comprenant au moins un peptide associé à l'hormone parathyroïde (PTH), de préférence PTH1-34, et un ou plusieurs agents destinés à améliorer l'administration par les muqueuses du PTH, afin de traiter ou de prévenir l'ostéoporose ou l'ostéopénie chez un mammifère, de préférence un humain.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)